Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/542248 stock hub

BOM/542248 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/542248is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

304.5M

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/542248

In the news

Latest news · BOM/542248

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E14.2

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC2.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/542248 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

161

Groups with data

Currency

INR

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	83
Employees Change	26%
Employees Change Percent	45.61
Enterprise value	INR 305.3M
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 304.5M
Price	INR 13
Price currency	INR
Rev Per Employee	9,840,578.31x
Sic	2834
Symbol	bom/542248
Website	https://www.deccanhealthcare.co.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.48%
EV Earnings	13.41x
EV/EBIT	9.09x
EV/EBITDA	6.36x
EV/Sales	0.37x
P/B ratio	0.28x
P/E ratio	14.22x
P/S ratio	0.37x
PE Ratio3 Y	56.07x
PE Ratio5 Y	58.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.11%
EBITDA Margin	5.88%
Gross margin	36.25%
Gross Profit	INR 296.1M
Gross Profit Growth	10.61%
Gross Profit Growth Q	7.49%
Gross Profit Growth3 Y	17.4%
Gross Profit Growth5 Y	11.9%
Net Income	INR 22.8M
Net Income Growth	95.73%
Net Income Growth Q	594.73%
Pretax Margin	3.84%
Profit Margin	2.79%
Profit Per Employee	INR 274,349
Roa5y	1.2
Roe5y	0.83
ROIC	2.24
Roic5y	1.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-26.55%
Cagr3y	-24.03%
Cagr5y	-16.94%
EPS Growth	93.62
EPS Growth Q	583.3
Revenue Growth	16.22x
Revenue Growth Q	-14.86x
Revenue Growth3 Y	30.94x
Revenue Growth5 Y	19.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 18.9M
Debt	INR 19.6M
Debt EBITDA	INR 0.41
Debt Equity	INR 0.02
Equity	INR 1.1B
Interest Coverage	15.17
Net Cash	INR -766,000
Net Cash By Market Cap	INR -0.25
Net Debt EBITDA	INR 0.02
Net Debt Equity	INR 0
Tangible Book Value	INR 1.1B
Tangible Book Value Per Share	INR 44.05
WACC	7.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-26.54%
200-day SMA	15.62
3Y total return	-56.17%
50-day SMA	11.69
50-day SMA vs 200-day SMA	50under200
5Y total return	-60.45%
All Time High	141.8
All Time High Change	-90.73%
All Time High Date	2019-01-24
All Time Low	6.65
All Time Low Change	97.74%
All Time Low Date	2026-03-30
ATR	0.73
Beta	0.57
Beta1y	1.13
Beta2y	0.54
Ch YTD	-11.21
High	13.35
High52	24.4
High52 Date	2025-05-22
High52ch	-46.72%
Low	12.5
Low52	6.65
Low52 Date	2026-03-30
Low52ch	95.49%
Ma50ch	12.48%
Price vs 200-day SMA	-15.82%
RSI	61.55
RSI Monthly	39.6
RSI Weekly	46.84
Sharpe ratio	-0.45x
Sortino ratio	-0.52
Total Return	-1.42%
Tr YTD	-11.21
Tr1m	31.9%
Tr1w	2.41%
Tr3m	-8.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 33.6M
Operating Income Growth	89.23
Operating Income Growth Q	537.1
Operating Income Growth3 Y	31.46
Operating Income Growth5 Y	6.9
Operating margin	4.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,731,819%
Shares Insiders	45.19%
Shares Out	23,425,513
Shares Qo Q	-1.02%
Shares Yo Y	1.42%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	24,842.25x
Bv Per Share	44.06
Ch1m	31.9
Ch1w	2.41
Ch1y	-26.54
Ch3m	-8.17
Ch3y	-56.17
Ch5y	-60.45
Ch6m	-18.88
Change	-1.14%
Change From Open	-2.62
Close	13.15
Days Gap	1.52
Depreciation Amortization	14,421,750
Dollar Volume	201,071
Earnings Date	2026-05-29
EBIT	INR 33.6M
EBITDA	INR 48M
EPS	INR 0.91
F Score	1
Fiscal Year End	March
Founded	1,996
Graham Number	30.10622
Graham Upside	131.6
Income Tax	INR 8.6M
Is Primary Listing	1
Last Earnings Date	2026-02-09
Last Report Date	2025-12-31
Ma150	14.19
Ma150ch	-7.3%
Ma20	12.2
Ma20ch	7.79%
Next Earnings Date	2026-05-29
Open	13.35
Position In Range	58.82
Price Date	2026-05-08
Price EBITDA	INR 6.34
Ptbv Ratio	0.28
Relative Volume	0.62x
Revenue	816,768,000x
Tax By Revenue	1.05x
Tax Rate	27.33%
Tr6m	-18.88%
Volume	15,467

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/542248 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/542248 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/542248?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+45.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.4%

Negative means the company is buying back shares.

Technical

BOM/542248 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.5

Neutral momentum band

Price vs 200-day MA

-15.8%

50/200-day relationship not available

Beta (5Y)

0.57

Less volatile than the market

Sharpe ratio

-0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/542248

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/542248 stock rating?

bom/542248 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/542248 analysis?

The full report lives at /stocks/bom/542248/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/542248?

The latest report frames bom/542248 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/542248 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.